Alibaba Group Holding Limited

Beijing Tide Pharmaceutical Co., Ltd.

Yanhao Zhang

Hongjun Wang

Yanping Zhao

Pan Pan

Yuanyuan Jiang

Yeming Wang

Yun Zheng

Jie Lin

Yong Xie

Xuelian Liu

Yinghui Xu

Xiaoqian Wang

Chenwei Xie

Huining Liang

Yuan Shen

Futian Fan

Provided is an EGFR kinase inhibitor according to general formula (I) and a pharmaceutical composition containing the inhibitor. The invention can be used to treat diseases related to EGFR kinase, such as cancer. Also provided is a preparation and use of the above inhibitor.

Compound for inhibiting and inducing degradation of EGFR kinase

Presenting information on similar objects relative to a target object is disclosed, including: obtaining a plurality of video frames; determining a target object in the plurality of video frames using a tracking recognition technique; determining time slice information corresponding to the target object; using the time slice information corresponding to the target object to determine one or more similar objects relative to the target object; receiving an indication to present information on the one or more similar objects relative to the target object; and outputting the information on the one or more similar objects relative to the target object.

Presenting information on similar objects relative to a target object from a plurality of video frames

Growing community of inventors

Beijing, China

Yanhao Zhang